Research & Development: Page 30

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    HealthTech

    Tiny Robots Tumble Through Organs to Deliver Drugs Trend Watch: From patient rides to telehealth specialty visits, healthtech continues to forge new paths for better patient outcomes. Tiny Robots Walk Through Colon to Deliver Drugs, Sample Tissue A rectangular robot as tiny as a few human hairs c...

    By PharmaVoice Team • Nov. 16, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    2021 Year in Preview: The Year to Come and the Year That Was

    Who knew? 2020 will be defined as one of the most tumultuous years in history: a global pandemic and civil strife giving way to innovation and greater collaboration. Even as COVID-19 vaccines make their way through safety trials and treatments receive expedited review and approval, the 2021 cryst...

    By Taren Grom • Nov. 16, 2020
  • cancer healthcare Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Oncology

    As investments in cancer R&D stay high, waves of innovative new treatments are on the horizon.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    SHOWCASE: Technology Solutions: Disrupting Innovation with Digital Solutions

    Healthcare is undergoing a massive transformation with increased emphasis on digital technologies in all areas. According to Deloitte research, biopharma companies recognize that digital transformation will aid product and service innovation, greater customer engagement, and improvements across R...

    By PharmaVoice Team • Nov. 16, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Virtual Trials: Navigating Change and Avoiding Blinds Spots

    As 2020 draws to a close, we reflect on the changes we have had to make in all facets of our lives due to the pandemic. Some were overdue and some are here to stay. Some were easy to adopt and others we resisted. Change of any sort, positive or negative, is known to be one of life’s great stresso...

    By Kenneth G. Faulkner • Nov. 16, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Four Ways Predictive Analytics Can Strengthen Your Commercialization Efforts

    Over the past few years, artificial intelligence (AI) and machine learning (ML) have been trending topics in healthcare but are now being propelled to the forefront of clinical decision support and care delivery. Some organizations, however, have been slow to adopt the utilization of predictive a...

    By Steve Mack • Nov. 16, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    A New Framework for Improving Brand Performance

    Why Managing Brand Performance is So Challenging Brand performance appears to be a straightforward concept to understand. However, the reality is that within pharmaceutical organizations, each business function has its own perspective of how brand performance should be planned for, monitored, and...

    By Pankaj Gupta • Nov. 16, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Telehealth: Ready or Not — <del>Here it Comes</del>… It's Here to Stay

    Our world is changing more rapidly than ever before, but certain constants remain imperative in the healthcare arena — human connection and access to education. Healthcare professionals (HCPs) need to be able to connect with their patients to properly assess their conditions. HCPs need access to ...

    By Christine Molbury • Nov. 16, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Next Chapter for Real World Evidence: Validating Data with the Patient Voice

    In June 2020, in accordance with the 21st Century Cures Act of 2016 and the Prescription Drug User Fee Act (PDUFA), the U.S. Food and Drug Administration (FDA) launched Project Patient Voice. This patient-focused drug development initiative facilitates systematic approaches to collecting and usin...

    By Ramita Tandon • Nov. 16, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    COVID-19: Silver Linings

    COVID-19 has stretched our industry to adjust to all types of new “normals," yet amid all of the disruption and loss of life, there are pockets of light that are expected to lift the life sciences and its people to new heights. Of all the industries that have been impacted across the globe, the l...

    By Taren Grom • Nov. 16, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Expanding the Spectrum of Clinical Trials

    In recent years, pharma and biotech companies have become more aware of the lack of representation of certain demographics in clinical trials and its resulting ramifications. Although the participation of women in clinical trials has improved in recent years, the participation of racial and ethni...

    By Carolyn Gretton • Nov. 16, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Centering on the Patient by Decentralizing Clinical Trials

    When it comes to decentralizing clinical trials, what was long a cracked door has been flung open wide by the COVID-19 pandemic. With COVID-19 sparking major upheaval in clinical trial execution, sponsors, CROs, and other supporters of drug development have been forced to adopt tools long used in...

    By Carolyn Gretton • Nov. 16, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Health Consumerism on the Rise

    COVID-19 has pushed the promise of healthcare consumerism into the open, creating a space where patients have a real voice in their healthcare decisions. The healthcare consumer of the future is arriving faster than anticipated, fueled by the COVID-19 pandemic. Health consumerism, which was begin...

    By Robin Robinson • Nov. 16, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Speak Out: Making Data Central to Your CNS and Pain Trials

    A Therapeutic-Area-Specific Approach to Data Capture Solutions For data capture, CNS and pain trials are demanding, with complicated eligibility criteria, extensive monitoring requirements, comprehensive data collection, and substantial demands on patients. To design a great solution, we consulte...

    By Kyle Hogan • Nov. 16, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Upfront

    Takeda’s Innovators in Science Award Takeda Pharmaceuticals and the New York Academy of Sciences are drawing attention to the urgent needs of patients worldwide affected by an estimated 7,000 rare diseases. The 2020 Innovators in Science Award recognizes scientists from around the globe for their...

    By PharmaVoice Team • Oct. 1, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    HealthTech

    Organ-on-a-Chip Transforms Drug Development Trend Watch: Healthtech Applications Run the Gamut from Chip Technology to EHRs, to Electronic Skin and Clinical Trials Draper’s Ex Vivo Immuno-oncology Dynamic Environment for Tumor biopsies (EVIDENT) is a microfluidic platform that maintains tumor fra...

    By PharmaVoice Team • Oct. 1, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Case Study: Leveraging AI for Meaningful Clinical Trials

    Clinical trial sponsors seeking to develop new drugs and therapies face unique challenges, particularly when it comes to understanding patient dosing and response to therapy. This aspect can be difficult, as patients often: Do not take their medicine regularly, or at all Take creative measures to...

    By Rich Christie • Oct. 1, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    AI and Drug Discovery

    Discovering and bringing new drugs to market is notoriously slow and costly for a reason. Science moves slowly because of the incredibly complex nature of human biology and the difficulty of sluggish recruitment of clinical trials. And in spite of greater investments in R&D by pharmaceutical ...

    By Claire Bonaci • Oct. 1, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Accessibility of AI: Innovation at Your Fingertips

    The availability of datasets keeps growing exponentially. With this we are witnessing an escalation of available new life-altering systems. Some of these tools are highly autonomous and can perform functions with little to no human intervention. Self-driving cars, rockets that land upright on dro...

    By Max Divak • Oct. 1, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Site Unseen? Virtual and Hybrid Trials the Way of the Future

    Decentralized trials create new opportunities for reaching more patients and safeguarding them during a pandemic, but what do they mean for sites? The clinical trial landscape has been going through a period of rapid and profound change. Even before the COVID-19 pandemic, trial sites have faced m...

    By Kim Ribbink • Oct. 1, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Innovator's Corner

    Turning on the Switch Fulcrum’s proprietary product engine identifies drug targets that can modulate gene expression to treat the known root cause of gene mis-expression. Bringing more than 30 years of R&D experience to his role as president and CEO of Fulcrum Therapeutics, Robert Gould, Ph....

    By Robert Gould • Sept. 1, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Turning Data into Storytelling

    Beyond communications skills, creating a good data story requires research. Nobody wants to listen to a boring story. And for some, data can be boring, or at best, confusing. Telling an enthralling story takes a certain skill, and when the topic is a mound of eye-glazing data and analysis, it bec...

    By Robin Robinson • Sept. 1, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Commanders & Chiefs: Chief Medical Officers

    Chief Medical Officers have a big remit when it comes to overseeing their organization’s clinical trial strategies as well as keeping the patient voice top of mind. Dr. David Andrews Tracking Neo-Antigens The biggest trend in the immuno-oncology space is the pursuit of a successful solid tumor im...

    By PharmaVoice Team • Sept. 1, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Mentors

    These champions of diversity and inclusion are dedicated to developing the next generation of leaders and setting an example for others to follow. An Ally for All Raising the bar… by bringing people together Peter Anastasiou Title: Executive VP & Head of North America Company: Lundbeck Indust...

    By PharmaVoice Team • Aug. 1, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Technologists

    Big data and technology are key drivers of future innovation in the industry, and these leaders are always looking forward to the next big idea. Creating a Digital Health Transformation Raising the bar… by delivering solutions that reach from bench to bedside Rama K. Kondru, Ph.D. Title: Executiv...

    By PharmaVoice Team • Aug. 1, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    SHOWCASE: Clinical Trial Solutions: Improving Trials with Technology

    Technology is taking center stage as a way to mitigate clinical challenges and improve patient outcomes. The clinical trials market is massive and continues to grow. According to a report from Grand View Research, the global clinical trials market will be worth $65.2 billion by 2025. At the same...

    By PharmaVoice Team • June 1, 2020